Pentasa
Pentasa is a medication containing Mesalazine, which is primarily used to treat inflammatory bowel diseases such as ulcerative colitis and Crohn's disease. These tablets work by reducing inflammation in the bowel, thereby alleviating symptoms like diarrhea, rectal bleeding, and abdominal pain. Mesalazine, the active ingredient, targets the colon to provide local anti-inflammatory effects. Pentasa is often used as a long-term treatment to maintain remission and prevent flare-ups. It is available in controlled-release tablets for effective delivery throughout the gastrointestinal tract. This medication is suitable for adult patients and can be an integral part of managing chronic intestinal conditions.Active substance:
MesalazinePharmachologic effect:
Pentasa is an anti-inflammatory drug that works by inhibiting the production of inflammatory mediators in the colon, thereby reducing inflammation in the intestinal lining.Indications:
- Ulcerative colitis
- Crohn's disease
Contraindications:
- Hypersensitivity to mesalazine or any of the excipients
- Severe liver impairment
- Severe renal impairment
Side effects:
In order of decreasing probability: Common: Headache, nausea, diarrhea, Uncommon: Rash, abdominal pain, vomiting, Rare: Pancreatitis, myocarditis, nephritis, Very rare: Blood disorders, liver dysfunction
Dosing and Administration:
The recommended dosage for adults is 2-4 grams per day, divided into two or three doses. Tablets should be swallowed whole, not crushed or chewed, and taken with water. The dosage may be adjusted based on the severity of the condition and the patient's response to treatment.
Storage:
Store at a temperature not exceeding 25°C (77°F).
Pentasa
in Cyrillic : Пентаса
SUBSTANCE
Mesalazine
DOSAGE FORM
tablets
MANUFACTURER
In Stock
available pack options :
| 500mg x 100 tablets | $93.80 |
